The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11
about
A point mutation in a herpesvirus polymerase determines neuropathogenicityExpression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA miceThe equine herpesvirus-1 (EHV-1) IR3 transcript downregulates expression of the IE gene and the absence of IR3 gene expression alters EHV-1 biological properties and virulence.Properties of an equine herpesvirus 1 mutant devoid of the internal inverted repeat sequence of the genomic short region.Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutantThe UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters.Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmissionThe early UL3 gene of equine herpesvirus-1 encodes a tegument protein not essential for replication or virulence in the mouseEquine herpesvirus type 1 modified live virus vaccines: quo vaditis?CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I.An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress.In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs.Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.Duck plague virus Glycoprotein J is functional but slightly impaired in viral replication and cell-to-cell spread.
P2860
Q28471604-80498484-E1A4-4892-9553-C0288A21B359Q33724313-5725654E-6720-4D03-8C5A-8A90715FD9ECQ34485898-B95BB5A2-1499-464A-8483-E37E7A1B6188Q34538271-500B808D-71E5-486A-8671-7826206A06A2Q34607906-CC7548AD-8AC2-49C9-8EA3-924FB9987409Q34699570-12C85F0B-0A1A-4A0A-B032-128F26D6649DQ35159988-00F3EA2E-8D86-492A-9B5C-811627C30CAFQ35256551-B5296747-653C-4D4D-9FCC-AAB2E92159D6Q36383825-3FEC1C72-8853-4907-9674-59C161AA5108Q36483291-2A7A9F25-45E5-45FB-8DCC-835507900338Q39406179-EDCC1FCE-206E-4D63-A157-C470D3090B97Q40043424-4E63EF0A-09C9-4B37-834B-B35363F6DD26Q40311665-265471CF-A6C7-4F95-B16A-269F10025A67Q40723103-3EE35F14-632A-48B6-841E-3950ADBB0D09Q41059046-040B5C55-57B7-4F9D-82DB-3E42D1D8D106Q41815389-A21E89EE-9B78-4FDA-A9FB-38CD3E6EF85DQ51743710-1427D635-C0FE-454C-8300-B16078CCA009
P2860
The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@ast
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@en
type
label
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@ast
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@en
prefLabel
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@ast
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@en
P2093
P2860
P1433
P1476
The truncated form of glycopro ...... EHV-1 wild-type strain RacL11
@en
P2093
Dennis J O'Callaghan
J Millar Whalley
Janet Wellington
Jens von Einem
Kerstin Osterrieder
P2860
P304
P356
10.1128/JVI.78.6.3003-3013.2004
P407
P577
2004-03-01T00:00:00Z